Indraprastha Medical (INDRAMEDCO) Stock Overview
Provides hospital services in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
INDRAMEDCO Community Fair Values
Create NarrativeSee what 13 others think this stock is worth. Follow their fair value or set your own to get alerts.
Indraprastha Medical Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹606.45 |
| 52 Week High | ₹624.70 |
| 52 Week Low | ₹307.25 |
| Beta | 0.57 |
| 1 Month Change | 33.14% |
| 3 Month Change | 33.70% |
| 1 Year Change | 48.79% |
| 3 Year Change | 731.89% |
| 5 Year Change | 1,120.22% |
| Change since IPO | 6,527.87% |
Recent News & Updates
Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation
Nov 01
Here's Why Indraprastha Medical (NSE:INDRAMEDCO) Has Caught The Eye Of Investors
Oct 09Recent updates
Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation
Nov 01Here's Why Indraprastha Medical (NSE:INDRAMEDCO) Has Caught The Eye Of Investors
Oct 09It Looks Like The CEO Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) May Be Underpaid Compared To Peers
Sep 18Indraprastha Medical (NSE:INDRAMEDCO) Is Due To Pay A Dividend Of ₹4.50
Sep 02Indraprastha Medical (NSE:INDRAMEDCO) Has Affirmed Its Dividend Of ₹4.50
Aug 09Not Many Are Piling Into Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Just Yet
Jun 28Is Now The Time To Put Indraprastha Medical (NSE:INDRAMEDCO) On Your Watchlist?
Mar 21Benign Growth For Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Underpins Stock's 29% Plummet
Mar 04The Trend Of High Returns At Indraprastha Medical (NSE:INDRAMEDCO) Has Us Very Interested
Dec 03Calculating The Fair Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Oct 14We Take A Look At Why Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Is Well Earned
Sep 18Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 30Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 11Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Soars 34% But It's A Story Of Risk Vs Reward
Aug 08Investors Should Be Encouraged By Indraprastha Medical's (NSE:INDRAMEDCO) Returns On Capital
Jun 12Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth
Apr 06Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E
Feb 01Why The 29% Return On Capital At Indraprastha Medical (NSE:INDRAMEDCO) Should Have Your Attention
Nov 03We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair
Sep 15Indraprastha Medical's (NSE:INDRAMEDCO) Dividend Will Be Increased To ₹3.00
Sep 10Indraprastha Medical's (NSE:INDRAMEDCO) Upcoming Dividend Will Be Larger Than Last Year's
Aug 27Indraprastha Medical (NSE:INDRAMEDCO) Is Paying Out A Larger Dividend Than Last Year
Aug 08Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)
Jul 31Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation
Jan 21We Think Indraprastha Medical's (NSE:INDRAMEDCO) Profit Is Only A Baseline For What They Can Achieve
Nov 12Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Nov 02Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)
May 12Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Jun 10Introducing Indraprastha Medical (NSE:INDRAMEDCO), A Stock That Climbed 24% In The Last Year
Feb 21Shareholder Returns
| INDRAMEDCO | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 11.4% | -1.1% | 0.3% |
| 1Y | 48.8% | 20.2% | 0.7% |
Return vs Industry: INDRAMEDCO exceeded the Indian Healthcare industry which returned 20.2% over the past year.
Return vs Market: INDRAMEDCO exceeded the Indian Market which returned 0.7% over the past year.
Price Volatility
| INDRAMEDCO volatility | |
|---|---|
| INDRAMEDCO Average Weekly Movement | 7.3% |
| Healthcare Industry Average Movement | 4.8% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in IN Market | 8.4% |
| 10% least volatile stocks in IN Market | 3.1% |
Stable Share Price: INDRAMEDCO's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: INDRAMEDCO's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 3,035 | Shivakumar Pattabhiraman | www.apollohospitals.com/delhi/ |
Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and organ transplant, as well as laboratory services, interventional medicine, preventive medicine, and sleep medicine. Indraprastha Medical Corporation Limited was founded in 1983 and is based in New Delhi, India.
Indraprastha Medical Corporation Limited Fundamentals Summary
| INDRAMEDCO fundamental statistics | |
|---|---|
| Market cap | ₹55.60b |
| Earnings (TTM) | ₹1.68b |
| Revenue (TTM) | ₹13.74b |
Is INDRAMEDCO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INDRAMEDCO income statement (TTM) | |
|---|---|
| Revenue | ₹13.74b |
| Cost of Revenue | ₹8.72b |
| Gross Profit | ₹5.01b |
| Other Expenses | ₹3.34b |
| Earnings | ₹1.68b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 18.29 |
| Gross Margin | 36.50% |
| Net Profit Margin | 12.21% |
| Debt/Equity Ratio | 5.5% |
How did INDRAMEDCO perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/01 01:38 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Indraprastha Medical Corporation Limited is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Himanshu Binani | Anand Rathi Shares and Stock Brokers Limited |
| Ranjit Kapadia | Centrum Broking Limited |